跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61 条关于
“DehydraTECH”
全部
61
临床试验
45
药物
3
机构
1
资讯
12
12个月前
Lexaria's DehydraTECH Technology Enhances Semaglutide Brain Delivery in Preclinical Study
去年
Lexaria Bioscience Advances DehydraTECH Platform to Enhance GLP-1 Drug Effectiveness
去年
Lexaria Bioscience Receives FDA Clearance for Phase 1b Hypertension Trial of DehydraTECH-CBD
去年
Lexaria's Oral Tirzepatide Study Achieves Dosing Milestone, Eyes on Data
去年
Lexaria's DehydraTECH GLP-1 Study Receives Ethics Board Approval, Aims to Enhance Oral Delivery of Diabetes and Weight Loss Drugs
8个月前
Lexaria's DehydraTECH-Semaglutide Shows 48% Reduction in Side Effects Compared to Rybelsus in Phase 1b Trial
去年
Lexaria Bioscience Initiates Phase 1b Study Evaluating DehydraTECH-Enhanced GLP-1 Drugs
11个月前
Lexaria Bioscience Expands Drug Delivery Platform Development with $4M Funding and Strategic Advisory Partnership
去年
Lexaria's Oral Tirzepatide Pilot Study Begins Dosing, Evaluating DehydraTECH Delivery
去年
Lexaria's Oral Tirzepatide Formulation Shows Reduced Side Effects, Comparable Efficacy to Injected Zepbound in Early Study
第 1 页,共 2 页
上一页
下一页